Abstract:Objective To investigate the inhibitory effects and related mechanisms of stimulation of α7 nicotinic acetylcholine receptor (αt7nAChR) on lipopolysaccharide (LPS)-induced inflammatory response in the mouse alveolar macrophages.Methods MH-S cells were cultured.(1) Cells were treated with LPS, and the expression of αTnAChR was detected;(2) Cells were treated with LPS, GTS-21,Vecuronium, LPS + GTS-21, LPS + Vecuronium and LPS + GTS-21 + Vecuronium separately, and the release of tumor necrosis factor-αα (TNF-α), high mobility group protein B1 (HMGB1), interleukin (IL)-6 and IL-10 was measured;(3) The expression of α7nAChR was knocked down by specific small interfering RNA (siRNA) before the same stimulations and measurements as above;(4) Activity of nuclear factor-κB (NF-κB) and janus kinase (JAK)-signal transducers and activators of transcription 3 (STAT3) was measured after treatment with GTS-21.Results Expression levels of α7nAChR mRNA and protein were increased by about 124％ and 88％ (P ＜0.05) after LPS stimulation, and the release of TNF-α, HMGB1, IL-6 and IL-10 was increased by 35.7, 18.5, 17.4 and 16.8 folds separately (P ＜ 0.05).The release of TNF-α, IL-6 and HMGB1 was reduced by about 64％, 56％ and 61％ respectively(P ＜0.05), and the release of IL-10 increased by approximately 13％ (P ＞ 0.05) after GTS-21 and LPS co-stimulation.When co-treatment with LPS + GTS-21 + Vecuronium, LPS-induced TNF-α, IL-6 and HMGB1 release was reduced by about 53％ , 50％ and 51％ (P ＜ 0.05), and the release of IL-10 increased by approximately 11％ (P ＞ 0.05), respectively.When the expression of α7nAChR was knocked down by specific siRNA, TNF-αt, IL-6 and HMGB1 release was reduced by about 4.0％, 0.3％ and 12.0％ when co-treatment with LPS + GTS-21 + Vecuronium (P ＞ 0.05).After co-treatment with LPS and GTS-21, the expression levels of p65 NF-κB were decreased by 57％ (P ＜ 0.05), while pSTAT3 activity increased by 130％ (P ＜ 0.05).Conclusion LPS could increase the expression of αα7nAChR and release of TNF-α, HMGB1, IL-6 and IL-10.Activation of α7nAChR could decrease the release of TNF-α, HMGB1 and IL-6 except for IL-10.This inhibitory effect can not be canceled by Vecuronium but be eliminated by knockdown of α7nAChR.GTS-21 may play a role by suppressing the activation of NF-κB and promoting JAK2-STAT3 pathway activation.

Human‐specific CHRFAM7A primes macrophages for a heightened pro‐inflammatory response at the earlier stage of inflammation

Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation

Inflammation Regulation Via an Agonist and Antagonists of Α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages.

TFEB-Mediated Pro-inflammatory Response in Murine Macrophages Induced by Acute Alpha7 Nicotinic Receptor Activation

Anti‐inflammatory effects of α7‐nicotinic ACh receptors are exerted through interactions with adenylyl cyclase‐6

Anti-inflammatory effects of CHRNA7 through interacting with adenylyl cyclase 6

Α7 Nicotinic Acetylcholine Receptor Mediates Lipopolysaccharide-Induced Inflammatory Response in the Mouse Macrophages

Inactivation of TMEM106A Promotes Lipopolysaccharide-Induced Inflammation Via the MAPK and NF-κB Signaling Pathways in Macrophages.

CHRFAM7A diversifies human immune adaption through Ca2+ signalling and actin cytoskeleton reorganization

SLAMF7 Regulates Inflammatory Response In Macrophage During Polymicrobial Sepsis

Polymorphisms in alpha 7 nicotinic acetylcholine receptor gene, CHRNA7, and its partially duplicated gene, CHRFAM7A, associate with increased inflammatory response in human peripheral mononuclear cells

Alpha 7 nicotinic acetylcholine receptors signaling boosts cell-cell interactions in macrophages effecting anti-inflammatory and organ protection

Inherent P2X7 Receptors Regulate Macrophage Functions during Inflammatory Diseases

SLAMF7 regulates the inflammatory response in macrophages during polymicrobial sepsis

An early regulatory mechanism of hyperinflammation by restricting monocyte contribution

Functional PU.1 in Macrophages Has a Pivotal Role in NF-κB Activation and Neutrophilic Lung Inflammation During Endotoxemia

CTRP6 promotes the macrophage inflammatory response, and its deficiency attenuates LPS-induced inflammation

The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model

Activating α7nAChR suppresses systemic inflammation by mitigating neuroinflammation of the medullary visceral zone in sepsis in a rat model

SLC38A6 Expression in Macrophages Exacerbates Pulmonary Inflammation

Role of Macrophage Colony Stimulating Factor and Interferon Regulatory Factor 7 in Modulating the Immune Profile of Mouse Testicular Macrophages